Drug Trials Snapshot: LYTGOBI

LYTGOBI is a drug used for the treatment of adults with a type of bile duct cancer (intrahepatic cholangiocarcinoma) that has spread to other parts of the body (metastatic) or cannot not be removed by surgery (unresectable).

Source: FDA Center for Drug Evaluation and Research - What's New - October 26, 2023 Category: Drugs & Pharmacology Authors: FDA Source Type: news